Cisplatin drives mitochondrial dysregulation in sensory hair cells.
David S LeeAngela SchraderJiaoxia ZouWee Han AngMark E WarcholLavinia SheetsPublished in: bioRxiv : the preprint server for biology (2024)
Cisplatin is a chemotherapy drug that causes permanent hearing loss by injuring cochlear hair cells. The mechanisms that initiate injury are not fully understood, but mitochondria have emerged as potential mediators of hair cell cytotoxicity. Using in vivo live imaging of hair cells in the zebrafish lateral-line organ expressing a genetically encoded indicator of cumulative mitochondrial activity, we first demonstrate that greater redox history increases susceptibility to cisplatin. Next, we conducted time-lapse imaging to understand dynamic changes in mitochondrial homeostasis and observe elevated mitochondrial and cytosolic calcium that surge prior to hair cell death. Furthermore, using a localized probe that fluoresces in the presence of cisplatin, we show that cisplatin directly accumulates in hair cell mitochondria, and this accumulation occurs before mitochondrial dysregulation and apoptosis. Our findings provide evidence that cisplatin directly targets hair cell mitochondria and support that the mitochondria are integral to cisplatin cytotoxicity in hair cells.
Keyphrases
- cell cycle arrest
- cell death
- induced apoptosis
- oxidative stress
- endoplasmic reticulum stress
- single cell
- cell therapy
- high resolution
- stem cells
- emergency department
- signaling pathway
- squamous cell carcinoma
- minimally invasive
- radiation therapy
- mesenchymal stem cells
- cell proliferation
- bone marrow
- mass spectrometry
- risk assessment
- adverse drug